|Bid||59.65 x 1100|
|Ask||59.66 x 1000|
|Day's Range||59.52 - 60.44|
|52 Week Range||57.04 - 85.97|
|Beta (5Y Monthly)||0.55|
|PE Ratio (TTM)||59.19|
|Forward Dividend & Yield||2.72 (4.51%)|
|Ex-Dividend Date||Dec 14, 2020|
|1y Target Est||N/A|
Pipeline and regulatory updates take centerstage in the biotech sector as Regeneron (REGN) and Gilead Sciences (GILD), among others, provide updates on their pipeline candidates.
If you reinvest your recurring dividend payment along the way, those returns can grow even faster. Three stocks that you can buy today at some pretty low prices and that pay more than the average S&P 500 yield of 2% include Gilead Sciences (NASDAQ: GILD), Enbridge (NYSE: ENB), and the Kellogg Company (NYSE: K). Gilead has been an intriguing coronavirus stock, enjoying lots of optimism surrounding its antiviral drug, remdesivir.
The Zacks Analyst Blog Highlights: Gilead, Eli Lilly, Incyte and Pfizer